tiprankstipranks
Trending News
More News >
ILEX Medical Ltd. (IL:ILX)
:ILX
Israel Market

Ilex Medical (ILX) Ratios

Compare
0 Followers

Ilex Medical Ratios

IL:ILX's free cash flow for Q3 2024 was 0.24. For the 2024 fiscal year, IL:ILX's free cash flow was decreased by and operating cash flow was 0.08. See a summary of the company’s cash flow.
Ratios
TTM
Dec 23Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
2.46 2.81 2.63 2.00 2.05
Quick Ratio
1.89 2.17 2.15 1.51 1.59
Cash Ratio
0.53 0.89 1.08 0.57 0.27
Solvency Ratio
0.25 0.53 0.83 0.48 0.38
Operating Cash Flow Ratio
0.29 0.31 1.13 0.65 0.45
Short-Term Operating Cash Flow Coverage
194.28 124.76 238.90 11.78 2.48
Net Current Asset Value
293.40M 348.75M 332.23M 223.28M 129.46M
Leverage Ratios
Debt-to-Assets Ratio
0.05 0.06 0.07 0.09 0.17
Debt-to-Equity Ratio
0.08 0.08 0.10 0.15 0.43
Debt-to-Capital Ratio
0.07 0.08 0.09 0.13 0.30
Long-Term Debt-to-Capital Ratio
<0.01 <0.01 <0.01 <0.01 0.08
Financial Leverage Ratio
1.63 1.47 1.52 1.76 2.61
Debt Service Coverage Ratio
32.74 70.99 75.92 8.87 2.50
Interest Coverage Ratio
29.20 98.39 124.23 61.36 29.67
Debt to Market Cap
<0.01 <0.01 <0.01 0.01 0.06
Interest Debt Per Share
4.55 4.71 5.39 6.48 9.93
Net Debt to EBITDA
-0.84 -0.79 -0.68 -0.50 0.41
Profitability Margins
Gross Profit Margin
24.91%32.67%35.76%28.64%30.56%
EBIT Margin
7.66%15.86%24.26%16.50%13.91%
EBITDA Margin
12.78%21.59%27.96%19.70%17.86%
Operating Profit Margin
8.33%18.12%23.56%15.46%12.67%
Pretax Profit Margin
7.46%15.67%24.07%16.25%13.48%
Net Profit Margin
5.47%11.70%18.61%12.74%9.50%
Continuous Operations Profit Margin
5.47%11.70%18.61%13.31%10.18%
Net Income Per EBT
73.32%74.68%77.34%78.43%70.49%
EBT Per EBIT
89.52%86.48%102.16%105.14%106.39%
Return on Assets (ROA)
5.01%11.36%22.57%15.48%10.36%
Return on Equity (ROE)
8.16%16.66%34.31%27.20%27.05%
Return on Capital Employed (ROCE)
10.51%23.48%39.37%29.25%20.47%
Return on Invested Capital (ROIC)
7.58%17.21%29.83%22.86%13.89%
Return on Tangible Assets
5.15%11.78%23.26%16.14%11.06%
Earnings Yield
7.27%9.03%10.77%9.19%7.21%
Efficiency Ratios
Receivables Turnover
3.25 3.51 4.82 3.95 3.04
Payables Turnover
4.06 4.13 5.48 4.15 4.32
Inventory Turnover
4.38 4.03 5.86 4.94 5.06
Fixed Asset Turnover
5.79 6.01 7.01 6.11 5.41
Asset Turnover
0.92 0.97 1.21 1.21 1.09
Working Capital Turnover Ratio
2.28 2.18 3.16 3.96 3.23
Cash Conversion Cycle
105.75 106.02 71.36 78.24 107.62
Days of Sales Outstanding
112.24 103.85 75.68 92.35 119.87
Days of Inventory Outstanding
83.38 90.59 62.29 73.86 72.20
Days of Payables Outstanding
89.87 88.43 66.61 87.97 84.45
Operating Cycle
195.62 194.45 137.97 166.21 192.08
Cash Flow Ratios
Operating Cash Flow Per Share
7.19 6.18 23.99 17.10 8.46
Free Cash Flow Per Share
2.53 3.67 20.21 12.75 5.34
CapEx Per Share
4.66 2.51 3.78 4.35 3.12
Free Cash Flow to Operating Cash Flow
0.35 0.59 0.84 0.75 0.63
Dividend Paid and CapEx Coverage Ratio
1.09 0.79 2.64 3.93 1.51
Capital Expenditure Coverage Ratio
1.54 2.46 6.35 3.93 2.72
Operating Cash Flow Coverage Ratio
1.67 1.35 4.61 2.73 0.88
Operating Cash Flow to Sales Ratio
0.09 0.08 0.26 0.19 0.13
Free Cash Flow Yield
4.04%3.66%12.43%10.36%6.42%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
13.75 11.08 9.29 10.88 13.87
Price-to-Sales (P/S) Ratio
0.75 1.30 1.73 1.39 1.32
Price-to-Book (P/B) Ratio
1.12 1.85 3.19 2.96 3.75
Price-to-Free Cash Flow (P/FCF) Ratio
24.75 27.34 8.04 9.65 15.59
Price-to-Operating Cash Flow Ratio
8.70 16.22 6.78 7.20 9.85
Price-to-Earnings Growth (PEG) Ratio
-0.28 -0.23 0.17 0.12 0.49
Price-to-Fair Value
1.12 1.85 3.19 2.96 3.75
Enterprise Value Multiple
5.04 5.21 5.51 6.54 7.79
Enterprise Value
EV to EBITDA
5.04 5.21 5.51 6.54 7.79
EV to Sales
0.64 1.13 1.54 1.29 1.39
EV to Free Cash Flow
21.21 23.73 7.16 8.96 16.45
EV to Operating Cash Flow
7.45 14.08 6.04 6.68 10.39
Tangible Book Value Per Share
53.20 51.51 48.72 38.59 28.55
Shareholders’ Equity Per Share
55.72 54.36 51.02 41.57 22.20
Tax and Other Ratios
Effective Tax Rate
0.27 0.25 0.23 0.18 0.25
Revenue Per Share
83.19 77.36 94.05 88.70 63.17
Net Income Per Share
4.55 9.05 17.51 11.30 6.00
Tax Burden
0.73 0.75 0.77 0.78 0.70
Interest Burden
0.97 0.99 0.99 0.98 0.97
Research & Development to Revenue
0.01 0.01 <0.01 <0.01 0.01
SG&A to Revenue
<0.01 0.01 <0.01 <0.01 0.01
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 <0.01
Income Quality
1.16 0.51 1.06 1.19 0.99
Currency in ILS
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis